Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental exposures on health outcomes, according to a new perspective in the ...

Research on Chronic Obstructive Pulmonary Disease (COPD) requires further examination of rural health disparities and the impact of sociocultural and environmental exposures on health outcomes, ...

AJMC®: What recent developments in the therapeutic landscape of chronic obstructive pulmonary disease (COPD) do you think have the greatest potential to shift how treatment is managed? Dr Martinez: ...

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that affects millions of people in the United ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

On Tuesday, the COPD Action Alliance and Representative Karen Gonzalez Pittman talked about the disease's impact across the ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

COPD emerged as an umbrella term for several respiratory diseases, including emphysema and chronic bronchitis, caused by lung damage. Because its effects are irreversible, early diagnosis and ...